Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis
Authors
Keywords
-
Journal
World Journal of Clinical Cases
Volume 7, Issue 20, Pages 3247-3258
Publisher
Baishideng Publishing Group Inc.
Online
2019-10-25
DOI
10.12998/wjcc.v7.i20.3247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peritoneal metastasis in gastric cancer: results from the German database
- (2019) Beate Rau et al. Gastric Cancer
- A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
- (2018) Hiroshi Matsumoto et al. BMC CANCER
- Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study
- (2018) Hiroyuki Ohnuma et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake
- (2017) Hiroki Hara et al. International Journal of Clinical Oncology
- Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases
- (2017) Zhong-He Ji et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination
- (2017) Shi Chen et al. World Journal of Surgical Oncology
- Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites
- (2017) Xuefeng Ni et al. Oncology Letters
- Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination
- (2016) Runcong Nie et al. Chinese Journal of Cancer Research
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway
- (2016) Tao Yin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?
- (2016) Inga Bekes et al. Molecular Cancer
- Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis
- (2015) Yong-Jiang Li et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Evaluation and treatment of malignant ascites secondary to gastric cancer
- (2015) Hiromichi Maeda WORLD JOURNAL OF GASTROENTEROLOGY
- Association of the intermediate filament nestin with cancer stage: a meta-analysis based on 223 positive/high nestin cases and 460 negative/low case-free controls
- (2015) Beilong Zhong et al. Oncotarget
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
- (2013) K. Shirao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Surgical Treatment for Patients with Krukenberg Tumor of Stomach Origin: Clinical Outcome and Prognostic Factors Analysis
- (2013) Wei Peng et al. PLoS One
- VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
- (2013) Sachio Fushida et al. OncoTargets and Therapy
- Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis
- (2012) Kohei Shitara et al. Gastric Cancer
- Significance of palliative gastrectomy for late-stage gastric cancer patients
- (2012) Shi Chen et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination
- (2011) Shigenobu Emoto et al. Gastric Cancer
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study
- (2010) Satoru Iwasa et al. International Journal of Clinical Oncology
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started